Back to KERX Stock Lookup

Keryx Biopharma (KERX) – Press Releases

Jul 24, 2014 05:00 PM Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology
Jul 24, 2014 05:00 PM Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology
Jun 18, 2014 08:30 AM Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate
Jun 17, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference
Jun 17, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference
Jun 5, 2014 08:30 AM Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference
Jun 5, 2014 08:30 AM Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference
May 22, 2014 04:30 PM Keryx Receives Notification of PDUFA Date Extension for Zerenex(TM)
May 22, 2014 04:30 PM Keryx Receives Notification of PDUFA Date Extension for Zerenex(TM)
May 8, 2014 07:00 AM Keryx Biopharmaceuticals, Inc. Announces First Quarter 2014 Financial Results
May 6, 2014 08:00 AM Keryx Biopharmaceuticals Announces Opening of Boston Office
May 5, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2014 Financial Results
May 5, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2014 Financial Results
Mar 17, 2014 08:30 AM Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo
Mar 12, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results
Mar 11, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2013 Financial Results
Mar 10, 2014 08:30 AM Keryx Biopharmaceuticals Announces Submission of a Marketing Authorization Application for Zerenex(TM) to the European Medicines Agency
Feb 26, 2014 08:30 AM Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences
Feb 18, 2014 08:30 AM Keryx Biopharmaceuticals Announces the Appointment of Abraham Ceesay as Vice President of Marketing
Feb 10, 2014 08:30 AM Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer
Feb 6, 2014 08:30 AM Keryx Biopharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference
Jan 21, 2014 08:30 AM Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
Jan 7, 2014 08:30 AM Keryx Biopharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Dec 18, 2013 08:30 AM Keryx Biopharmaceuticals Announces Issuance of U.S. Patent for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate
Dec 9, 2013 08:30 AM Keryx Biopharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference

Back to KERX Stock Lookup